The DOI matches its Crossref record.
Age is an independent prognostic factor in rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group
Abstract
Background: Although age <1 year at diagnosis has been associated with a worse prognosis in rhabdomyosarcoma (RMS), the relationship of age at diagnosis to clinical presentation and outcome has not been evaluated carefully. We reviewed data from recent Intergroup Rhabdomyosarcoma Study Committee (later called Group, IRSG) trials to examine this relationship in order to estimate prognosis more accurately and further refine treatment. Procedure: We used data from IRS‐III, ‐IV Pilot, and ‐IV (1983–97, N = 2,343) to study the relationship of patient age with clinical features and prognosis in a large cohort of patients treated with contemporary therapy. Results: We showed that, after adjusting for important prognostic factors, age was an independent risk factor for treatment failure and patients could be classified into three failure‐risk categories based on age (i.e., <1 year; 1–9 years; >10 years). Infants and adolescents were more likely to have unfavorable features, including alveolar or undifferentiated tumors and advanced Group and Stage, and also had significantly poorer failure‐free survival (FFS) than did children aged 1–9 (53 and 51% vs. 72%,P < 0.001). Although there was a difference in FFS among age categories, there was no evidence that age influences outcome within the three categories. Conclusions: Since age relates independently to outcome after adjustment for known risk factors, it is likely that other factors, including perhaps patients' tolerance of protocol‐specified therapy, explain this relationship. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oberlin, O., Rey, A., Lyden, E., Bisogno, G., Stevens, M. C. G., Meyer, W. H., Carli, M., & Anderson, J. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7207 · Cited by 484
Self-citationMalempati, S., & Hawkins, D. S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24118 · Cited by 422
Ferrari, A., Sultan, I., Huang, T. T., Rodriguez‐Galindo, C., Shehadeh, A., Meazza, C., Ness, K. K., Casanova, M., & Spunt, S. L. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23252 · Cited by 376
Rhabdomyosarcomas in Adults and Children: An Update
Parham, D. M., & Ellison, D. A. (2006) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2006-130-1454-riaaca · Cited by 333
Self-citationChallenges in the recruitment of adolescents and young adults to cancer clinical trials
Burke, M. E., Albritton, K., & Marina, N. (2007) · Cancer · doi:10.1002/cncr.23060 · Cited by 181
Tai, E., Buchanan, N., Westervelt, L., Elimam, D., & Lawvere, S. (2014) · Pediatrics · doi:10.1542/peds.2014-0122c · Cited by 39
Metadata
- Authors
- Joshi, D., Anderson, J. R., Paidas, C., Breneman, J., Parham, D. M., & Crist, W.
- Venue
- Pediatric Blood & Cancer
- Publisher
- Wiley
- Published
- 2003-10-29
- Volume
- 42
- Issue
- 1
- Pages
- 64-73
- ISSN
- 1545-5009 (ISSN-L)
- 1545-5017
- OpenAlex
- W2066439079
- Cited by
- 232
- References
- 0
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.